Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro slows the rate at which your stomach empties, and that is precisely why surgical teams ask patients to stop it before an operation. Food and fluid that would normally have cleared can remain in the stomach hours longer than expected, raising the risk of aspiration (inhaling stomach contents into the lungs) during anaesthesia. This is a well-established safety concern, not a precaution unique to Mounjaro, and NHS England's guidance on weight-management injections is explicit that patients should inform their healthcare team, including their anaesthetist, before any procedure. Because Mounjaro is a prescription-only medicine, the decision about when to pause it sits with your prescriber and surgical team together — not with you alone, and not with a single blanket rule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide (the active medicine in Mounjaro) activates both GIP and GLP-1 receptors, two gut-hormone pathways involved in appetite and digestion. One consequence of activating these receptors is a meaningful reduction in how quickly food travels from the stomach into the small intestine. In everyday life, that slowing is part of how the medicine reduces hunger. In a surgical setting, it creates a specific hazard.
Standard pre-operative fasting instructions are built around the assumption that a healthy stomach empties at a predictable rate: typically two hours for clear fluids and six hours for a light meal. Mounjaro disrupts that assumption. Studies using gastric ultrasound have found residual stomach content in patients who had fasted correctly by standard criteria but were taking GLP-1 medicines, including tirzepatide. If a patient vomits or regurgitates under anaesthesia, aspirating that material into the lungs can cause serious harm, including aspiration pneumonia.
This is not a theoretical concern raised late in Mounjaro's development. The NHS England page on weight-management injections specifically advises patients to tell their healthcare team and anaesthetist that they are on tirzepatide before any surgical procedure, and our page on what you need to know about tirzepatide before surgery sets out exactly why that conversation matters. Surgical societies across the UK and internationally have issued guidance for theatre teams as a result of exactly this mechanism.
This is a question our prescribers hear most weeks, and the honest answer is: it depends, and no single number fits every situation. Several variables shape the advice your anaesthetist will give.
The dose matters. At higher maintenance doses (10mg, 12.5mg, 15mg) gastric emptying slows more than at the starting 2.5mg. The type of procedure matters too: a minor procedure under light sedation carries a different risk profile from abdominal surgery under general anaesthesia. Your individual gastric function, any concurrent medicines and your clinical history all feed into the calculation.
Emerging guidance from anaesthetic societies has suggested periods ranging from one weekly injection cycle up to several weeks before an elective procedure, depending on dose and procedure type. The specific question of when to stop Mounjaro before surgery is covered in more detail on its own page, but the core message is this: only the anaesthetist and your prescriber, who know your full picture, can give you a number that is safe for your operation. Do not rely on general figures read online, share them with your clinical team and let them confirm or adjust.
For planned procedures, your surgeon's pre-assessment team should ask about all regular medicines. If they do not ask and you are taking Mounjaro, raise it yourself. For urgent or emergency surgery, inform the team as soon as possible so they can plan airway management accordingly.
The practical steps are straightforward, even if the clinical reasoning behind them is nuanced. First, tell every member of your surgical team (your surgeon, the anaesthetist and the pre-assessment nurse) that you take Mounjaro. Take your pen with you to any pre-operative appointment so they can confirm the dose and strength.
Second, contact your prescriber well in advance of any planned procedure. Your Mounjaro prescriber can liaise with, or provide a letter for, the anaesthetic team confirming your dose and when your most recent injection was. You can find guidance on stopping Mounjaro before surgery to help you frame that conversation, but the final decision on timing belongs to your clinical team.
Third, do not adjust your injection schedule independently. Stopping Mounjaro earlier than necessary may affect your weight, your blood sugar if you also have type 2 diabetes and your overall wellbeing. Starting again after surgery also requires clinical input, recovery, oral intake and medication absorption all interact. If you are unsure whether your upcoming procedure means you need to pause treatment, our page on whether you need to stop Mounjaro before surgery can help you work out the right questions to raise with your clinical team. The NHS patient information for tirzepatide reinforces that any changes to your treatment schedule should be made with your prescriber, not unilaterally.
If you need to get in touch with the team managing your Mounjaro prescription at nume (sorry, at our pharmacy) you can reach the aftercare team seven days a week through the contact page.
Yes, and it is worth being clear about the limits of current evidence. Much of the early guidance on GLP-1 medicines and aspiration risk was extrapolated from case reports and small ultrasound studies, rather than large randomised controlled trials specifically designed to answer this question. Since then, more data has emerged, but the exact washout period that completely eliminates gastric-emptying delay for tirzepatide at each dose has not been definitively established through a large prospective study.
What is clear is that the risk is real enough that anaesthetic societies and NHS England have both moved to formal guidance. What is less certain is the precise dose-response relationship and whether, for example, a patient on 5mg for six months faces meaningfully different risk from one who has just titrated to 12.5mg. For patients exploring what the surgical context means alongside their broader treatment journey, the page on Mounjaro and surgery covers the wider picture.
If you are considering starting Mounjaro and have planned surgery in the coming weeks or months, raise that timing at the consultation stage. A prescriber can factor it into the conversation about whether and when to begin treatment. You can start your free consultation and our clinical team will review your full situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.